These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36297533)

  • 1. Cyclodextrin Derivatives as Promising Solubilizers to Enhance the Biological Activity of Rosmarinic Acid.
    Stasiłowicz-Krzemień A; Rosiak N; Płazińska A; Płaziński W; Miklaszewski A; Tykarska E; Cielecka-Piontek J
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Systems of Naringenin with Solubilizers Expand Its Capability to Prevent Neurodegenerative Diseases.
    Stasiłowicz-Krzemień A; Gołębiewski M; Płazińska A; Płaziński W; Miklaszewski A; Żarowski M; Adamska-Jernaś Z; Cielecka-Piontek J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inclusion of Tolfenamic Acid into Cyclodextrins Stimulated by Microenvironmental pH Modification as a Way to Increase the Anti-Migraine Effect.
    Stasiłowicz A; Tykarska E; Rosiak N; Sałat K; Furgała-Wojas A; Plech T; Lewandowska K; Pikosz K; Pawłowicz K; Cielecka-Piontek J
    J Pain Res; 2021; 14():981-992. PubMed ID: 33883930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanochemical Approach to Obtaining a Multicomponent Fisetin Delivery System Improving Its Solubility and Biological Activity.
    Rosiak N; Tykarska E; Cielecka-Piontek J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous Inclusion Complexes: Molecular Interactions of Hesperidin and Hesperetin with HP-Β-CD and Their Biological Effects.
    Wdowiak K; Rosiak N; Tykarska E; Żarowski M; Płazińska A; Płaziński W; Cielecka-Piontek J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL; Liu X; Thenmozhiyal JC; Ho PC
    Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectroscopic study and antioxidant properties of the inclusion complexes of rosmarinic acid with natural and derivative cyclodextrins.
    Celik SE; Ozyürek M; Tufan AN; Güçlü K; Apak R
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1615-24. PubMed ID: 21377406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Antioxidant and Neuroprotective Properties of Pterostilbene (Resveratrol Derivative) in Amorphous Solid Dispersions.
    Rosiak N; Tykarska E; Cielecka-Piontek J
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of Piperine with Hydroxypropyl-β-Cyclodextrin as a Multifunctional System.
    Stasiłowicz A; Rosiak N; Tykarska E; Kozak M; Jenczyk J; Szulc P; Kobus-Cisowska J; Lewandowska K; Płazińska A; Płaziński W; Cielecka-Piontek J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
    Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
    Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.
    Fatmi S; Bournine L; Iguer-Ouada M; Lahiani-Skiba M; Bouchal F; Skiba M
    Acta Pol Pharm; 2015; 72(1):179-92. PubMed ID: 25850214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
    Wang L; Li S; Cai H; Liu X; Feng T; Zhao X
    J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
    Celebioglu A; Uyar T
    J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.